// App-Quantinova.ai

1618 : Thromboxane A2 receptor controls migration and metastasis of triple-negative breast cancer cells

Researchers

Presenter

  • Yuanqin Zhang

Principal Investigators

  • Xuejing Zhang

  • Daotai Nie

Medical Centers

  • Simmons Cancer Institute at SIU, Springfield, IL.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Thromboxane A2 Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved